期刊文献+

难治性结核性胸腔积液中异烟肼浓度的检测和对比 被引量:10

Refractory tuberculous pleural effusion of concentration of isoniazid in detection and contrast
暂未订购
导出
摘要 目的检测难治性包裹性结核性胸腔积液中异烟肼的药物浓度。方法对口服异烟肼、异烟肼直接注入包裹性胸腔积液中,检测胸腔积液和血液中异烟肼的浓度。结果口服异烟肼后包裹性胸腔积液中异烟肼的浓度(0.29±0.34)远低于血液中异烟肼的浓度(3.04±1.75);异烟肼直接注入包裹性胸腔积液中异烟肼的浓度(1.62±0.95)远高于血液中异烟肼的浓度(0.25±0.17),以后随注药次数增加,胸腔积液内异烟肼浓度越来越高(3.97±0.94,8.11±2.4),血液中异烟肼浓度无显著增加(0.21±0.26,0.32±0.14)。结论异烟肼直接注入包裹性胸腔积液能明显提高胸腔积液内的药物浓度,是治疗难治性结核性胸腔积液的有效手段。 Objective Detection of refractory encapsulated tuberculous pleura1 effusion in isoniazid drug concentration. Methods On oral isoniazid, isoniazid injected directly into the parcel pleural effusion, detection of pleural effusion and blood isoniazid. Results Oral isoniazid after encapsulated pleural effusion in isoniazid (0. 29 ± 0. 34 ) is far lower than the blood isoniazid ( 3.04 ± 1.75 ) ; Isoniazid injec- ted directly into the encapsulated pleural effusion in isoniazid ( 1.62 ±0. 95 ) than in blood isoniazid (0. 25± 0. 17 ), Subsequent to the in- jection times increasing, pleura] effusion endometriosis smoke hydrazine concentration becomes higher (3.97 ± 0.94,8. 11± 2.4 ) , no sig- nificant increase in blood concentration of isoniazid (0. 21 ± 0.26,0. 32 ± 0. 14). Conclusions Isoniazid injected directly into the parcel pleural effusion can obviously improve the drug concentrations in pleural effusion, is refractory to treatment of tuberculous pleural effusion by effective means.
机构地区 南京市胸科医院
出处 《临床肺科杂志》 2013年第3期433-434,共2页 Journal of Clinical Pulmonary Medicine
关键词 难治性 结核性 异烟肼 浓度 Refractory Tuberculous Isoniazid Concentration
  • 相关文献

参考文献5

二级参考文献19

  • 1陆兰英,王卫华,曾庆志,袁宝东,黄健.武汉地区耐多药结核病危险因素的病例对照研究[J].中国防痨杂志,2005,27(5):340-342. 被引量:15
  • 2陈建,李宁秀,万康林,杨光京,王庆.四川和安徽两省结核耐药危险因素分析[J].四川大学学报(医学版),2007,38(1):135-137. 被引量:19
  • 3Kim HJ,Kang CH,Kim YT,et al. Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis. Eur Respir J,2006,28 (3) :576 -580.
  • 4薛承岩 孙立新 等.结核性胸腔积液的诊断[J].中华结核呼吸杂志,2000,23:396-396.
  • 5Dahl ML, Sjoqvist F.Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics[J]. Ther Drug Monit,2000,22(1) : 114.
  • 6Lennard L. Therapeutic drug monitoring of antimetabolic cytotoxic drugs[J] .BrJ Clin Pharmacol, 1999, 47(2) : 131.
  • 7Seifart HI, Gent WL, Parkin DP, et al. High- performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids[ J ]. J Chromatography B, 1995,674: 269.
  • 8Takeo D, Masami M, Tomokazu S. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N - acetyhransferase in human liver[J] .J Biological Chem , 1990,265:12 757.
  • 9Tomoko K, Yusuke T, Shinji C, et al. N - acetyltransferase 2 genotype correlated with isoniazid acetylationin Japanese tuberculous patients[J] .Biol Pharm Bull,2001,24(5) : 544.
  • 10Kim HJ, Lee HJ, Kwon S-Y, et al. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest,2006, 129 : 1253 - 1258.

共引文献86

同被引文献81

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部